billHR8784•Event Wednesday, May 13, 2026Analyzed

Bereaved Parents Rights Act

Neutral

Summary

The Bereaved Parents Rights Act (HR8784) is an early-stage bill requiring hospitals and birth centers to notify parents of fetal disposition options after miscarriage or stillbirth. It imposes no direct spending, tax changes, or market-moving mandates on publicly traded companies. No actionable market signal for retail investors.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

1.No direct financial impact on any publicly traded company.
2.Bill is in early legislative stage with low momentum.
3.No funding, tax changes, or procurement mechanisms are included.

Market Implications

No market implications. The bill does not affect revenue, costs, or competitive positioning for any publicly traded company. Retail investors should ignore this legislation.

Full Analysis

1) On May 13, 2026, Rep. Cammack (R-FL) introduced HR8784, the Bereaved Parents Rights Act. The bill was referred to the Committees on Ways and Means and Energy and Commerce. It is in an early legislative stage with only 6 cosponsors and no further action. 2) The bill amends the Social Security Act to require hospitals and freestanding birth centers to notify parents of their rights regarding fetal disposition (burial, cremation, or hospital disposal). It does not authorize or appropriate any federal funds. No tax credits, grants, or procurement programs are created. 3) The bill's requirements apply to healthcare providers, but the compliance burden is administrative (notification forms) and does not materially affect revenue or costs for any publicly traded company. Hospitals (e.g., HCA, THC, UHS) face negligible incremental costs. No pure-play tickers are directly impacted. 4) No real market data is provided for healthcare stocks. The bill has no discernible effect on competitive dynamics. 5) The bill must pass both committees, then the House, then the Senate, then be signed into law. Given early stage and limited cosponsor support, passage is uncertain and distant.

Connected Signals

Matched on shared policy language across AI analyses, with ticker & timing weight

BillBullish

Save Struggling Hospitals Act

Shared: Hospitals · HcaCYH17% match

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderApr 30, 2026

Promoting Efficiency, Accountability, and Performance in Federal Contracting

This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.

$BA $LMT $RTX $GD $NOC $SAIC

8/10Source

Exec OrderApr 18, 2026

Accelerating Medical Treatments for Serious Mental Illness

This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.

$CMPS $MNMD $GHRS $ATAI $CYBN $NUMI

8/10Source